Buformin

Buformin

SCHEMBL3455307

CCCCNC(=N)NC(=N)N.Cl.F

nearest known ligand 0.41

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Buformin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIN2D known ✓ O15399 1/20 0.41
GRIN3B known ✓ O60391 1/20 0.41
GRIN1 known ✓ Q05586 1/20 0.41
GRIN2A known ✓ Q12879 1/20 0.41
GRIN2B known ✓ Q13224 1/20 0.41
GRIN2C known ✓ Q14957 1/20 0.41
GRIN3A known ✓ Q8TCU5 1/20 0.41
SIGMAR1 known ✓ Q99720 1/20 0.41
ACHE known ✓ P22303 8/20 0.38
SPHK1 Q9NYA1 4/20 0.39
EPHX1 P07099 4/20 0.36
SPHK2 Q9NRA0 1/20 0.34
MMP2 P08253 1/20 0.34
NOS3 P29474 1/20 0.33
NOS1 P29475 1/20 0.33
NOS2 P35228 1/20 0.33
MEN1 O00255 1/20 0.33
HTT P42858 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Buformin SCHEMBL5324403 1.00 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL15669256 0.98 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL6018 0.98 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL3644254 0.98 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL749659 0.98 GRIN2D (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL4235633 0.96 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL1048416 0.96 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL22436277 0.96 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL4656049 0.96 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Buformin SCHEMBL8432153 0.96 GRIN2D (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3194410-B1 METHOD FOR PURIFYING HALOGENATED OLIGOSILANES BAUCH CHRISTIAN (DE) 2024-03-13 EP disclosed
WO-2020115111-A2 METHOD FOR FORMING NANOSTRUCTURES ON A SURFACE AND OPTICAL ELEMENT CARL ZEISS SMT GMBH (DE) 2020-06-11 WO disclosed
EP-3194410-A1 METHOD FOR PURIFYING HALOGENATED OLIGOSILANES PSC Polysilane Chemicals GmbH (DE) 2017-07-26 EP disclosed
EP-2735018-B1 METHOD AND DEVICE FOR PRODUCING LOW-PARTICLE LAYERS ON SUBSTRATES FRAUNHOFER GES FORSCHUNG (DE) 2016-10-19 EP disclosed
EP-3051321-A1 METHOD FOR PRODUCING A REFLECTION-REDUCING LAYER SYSTEM AND REFLECTION-REDUCING COATING SYSTEM Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2016-08-03 EP disclosed
WO-2016037601-A1 METHOD FOR PURIFYING HALOGENATED OLIGOSILANES PSC POLYSILANE CHEMICALS GMBH (DE) 2016-03-17 WO disclosed
WO-2015058825-A1 PHOSPHORS MERCK PATENT GMBH (DE) 2015-04-30 WO disclosed
EP-2735018-A1 METHOD AND DEVICE FOR PRODUCING LOW-PARTICLE LAYERS ON SUBSTRATES Fraunhofer Gesellschaft zur Förderung der angewandten Forschung E.V. (DE) 2014-05-28 EP disclosed
EP-2650730-A2 Optical element and method Carl Zeiss SMT GmbH (DE) 2013-10-16 EP disclosed
WO-2013011149-A1 METHOD AND DEVICE FOR PRODUCING LOW-PARTICLE LAYERS ON SUBSTRATES Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. (DE) 2013-01-24 WO disclosed
WO-1997049985-A1 DEVICE FOR MEASURING THE PARTIAL PRESSURE OF GASES DISSOLVED IN LIQUIDS EUROFERM GMBH (DE) 1997-12-31 WO disclosed
WO-1996019723-A2 DEVICE FOR MEASURING THE PARTIAL PRESSURE OF GASES DISSOLVED IN LIQUIDS EuroFerm Gesellschaft für Fermentation und Messtechnik mbH (DE) 1996-06-27 WO disclosed
EP-0438646-B1 Rearview mirror for vehicles, specially for automotive vehicles DEUTSCHE SPEZIALGLAS AG (DE) 1995-03-01 EP disclosed
EP-0374094-B1 PROCESS FOR DEFORMING A METAL PIECE GEBRÀœDER SULZER AKTIENGESELLSCHAFT (CH) 1993-05-19 EP disclosed
EP-0438646-A1 Rearview mirror for vehicles, specially for automotive vehicles DEUTSCHE SPEZIALGLAS AG (DE) 1991-07-31 EP disclosed
EP-0088372-B2 PROCESS FOR THE PRODUCTION OF SYNTHETIC HECTORITE HOECHST AKTIENGESELLSCHAFT (DE) 1990-08-29 EP disclosed
EP-0374094-A1 Process for deforming a metal piece GEBRÀœDER SULZER AKTIENGESELLSCHAFT (CH) 1990-06-20 EP disclosed
EP-0088372-B1 PROCESS FOR THE PRODUCTION OF SYNTHETIC HECTORITE HOECHST AKTIENGESELLSCHAFT (DE) 1986-11-05 EP disclosed
EP-0195301-A2 Stabilized red phosphorus and use thereof for flame-resistant thermoplastic polyamide mouldings BAYER AG (DE) 1986-09-24 EP disclosed
EP-0088372-A1 Process for the production of synthetic hectorite HOECHST AKTIENGESELLSCHAFT (DE) 1983-09-14 EP disclosed